中恆集團(600252.SH):擬出資2.97億元參設投資基金
格隆匯6月17日丨中恆集團(600252.SH)公佈,為更好的貫徹公司發展戰略,加大資本運作力度,實現內生式與外延式發展,雙輪驅動,維護市值,提升股東回報,公司擬與力合科創創投合作,採用有限合夥企業形式發起設立中恆力合醫藥健康股權投資合夥企業(有限合夥)(暫定名,最終名稱以市場監督管理機構登記名稱為準,以下簡稱“投資基金”、“基金”、“合夥企業”),力合科創創投將作為普通合夥人、執行事務合夥人及基金管理人。投資基金總規模擬定為人民幣30,000萬元,公司出資人民幣29,700萬元,佔基金總規模的99%;力合科創創投出資人民幣300萬元,佔基金總規模的1%。
投資佈局符合醫療醫藥產業未來技術發展方向的創新藥、醫療器械、醫療檢測與診斷、原料藥等領域,結合中恆集團在醫藥領域的行業經驗,藉助專業投資管理機構的項目資源、投資經驗和專業能力,尋找、篩選符合公司戰略方向的醫療醫藥投資項目,同時凝聚資源、聚集人才,努力打造公司可持續發展能力和核心競爭力,不斷提升公司市值,為股東創造價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.